SHAH RAJESH has a total of 21 patent applications. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and it methods for management are HENDERSON MORLEY PLC, NORDIC VACCINE TECHNOLOGY AS and ONYVAX LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 4 | |
#4 | Australia | 3 | |
#5 | South Africa | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | IT methods for management | |
#4 | Control |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Coin-freed | |
#5 | Data processing systems |
# | Name | Total Patents |
---|---|---|
#1 | Shah Rajesh | 21 |
Publication | Filing date | Title |
---|---|---|
US2014143077A1 | Automated Print and Digital Media and Communications Vending Kiosk | |
WO2013179302A1 | Oral anti-inflammatory formulation comprising potentised cytokine | |
WO2010134086A1 | Medicinal formulation containing selected cytokines | |
EP2142200A1 | Homeopathy-based formulation | |
WO2008136012A1 | Oral medicinal preparations | |
EP2125009A1 | Medicinal formulation containing a combination of hiv type i and hiv type ii | |
WO2008078331A1 | Medicinal formulation for the treatment for hepatitis c | |
EP2111232A1 | A novel medicinal formulation for inducing an immune response in patients with chronic and recurring infections |